Clinical trials
Active, not recruiting Melanoma trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Regeneron Pharmaceuticals | 2 |
| Amgen | 1 |
| Erasca, Inc. | 1 |
| GlaxoSmithKline | 1 |
| HUYABIO International, LLC. | 1 |
| IO Biotech | 1 |
| Pfizer | 1 |
| Pierre Fabre Medicament | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 11 |
| Skin Neoplasms | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Ependymoma | 1 |
| Glioblastoma | 1 |
| Hepatoblastoma | 1 |
| Hodgkin Disease | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.